EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications

Kamil Siekacz iD, Anna Kumor-Kisielewska, Joanna Miłkowska-Dymanowska iD, Małgorzata Pietrusińska, Krystian Bartczak iD, Sebastian Majewski iD, Adam Stańczyk, Wojciech J Piotrowski iD, Adam J Białas iD

Journal of Clinical Medicine · 25.06.2023 · 12 (13) · 4253

DOI: 10.3390/jcm12134253 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 25.06.2023. Verfasst von Kamil Siekacz und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pneumology, Medical University of Lodz, 90-419 Lodz, Poland. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The role of mitochondria in post coronavirus disease 2019 (post-COVID-19) complications is unclear, especially in the long-term pulmonary complications. This study aims to investigate the association between post-COVID-19 pulmonary complications and mitochondrial regulatory proteins in the context of oxidative stress. Methodology: Patients who had recovered from COVID-19 were enrolled. According to the evidence of persistent interstitial lung lesions on computed tomography (CT), patients were divided into a long-term pulmonary complications group (P(+)) and a control group without long-term pulmonary complications (P(−)). We randomly selected 80 patients for investigation (40 subjects for each group). Biomarkers levels were determined by enzyme-linked immunosorbent assay (ELISA).

Results

The serum concentrations of mitochondrial regulatory proteins were significantly higher in the P(+) group, including PTEN-induced kinase 1 (PINK1): 1.62 [1.02–2.29] ng/mL vs. 1.34 [0.94–1.74] ng/mL (p = 0.046); Dynamin-1-like protein (DNM1L): 1.6 [0.9–2.4] ng/mL IQR vs. 0.9 [0.5–1.6] ng/mL (p = 0.004); and Mitofusin-2 (MFN2): 0.3 [0.2–0.5] ng/mL vs. 0.2 [0.1–0.3] ng/mL IQR (p = 0.001). Patients from the P(+) group also had higher serum levels of chemokine ligand 18 (PARC, CCL18), IL-6, and tumour necrosis factor-alpha (TNF-α) cytokines than the P(−) group. The concentration of interferon alpha (IFN-α) was decreased in the P(+) group. Furthermore, we observed statistically significant correlations between the advanced glycation end product (sRAGE) and TNF-α (Pearson’s factor R = 0.637; p < 0.001) and between serum levels of DNM1L and IFN-α (Pearson’s factor R = 0.501; p = 0.002) in P(+) patients.

Conclusions

Elevated concentrations of mitochondrial biomarkers in post-COVID-19 patients with long-term pulmonary complications indicate their possible role in the pathobiology of COVID-19 pulmonary sequelae. Oxidative stress is associated with the immune response and inflammation after COVID-19. TNF-α could be a promising biomarker for predicting pulmonary complications and may be a potential target for therapeutic intervention in patients with post-COVID-19 complications.

Schlagwörter

Stichwörter der Autor:innen

CCL18DNM1LIFN-αPINK1SARS-CoV-2TNF-αmitophagyoxidative stresspost-COVID-19pulmonary fibrosissRAGE

Autor:innen und Institutionen

  • Department of Pneumology, Medical University of Lodz, 90-419 Lodz, Poland.
  • Department of Clinical Pharmacology, Medical University of Lodz, 90-419 Lodz, Poland.
  • Department of Pulmonary Rehabilitation, Regional Medical Center for Lung Diseases and Rehabilitation, Blessed Rafal Chylinski Memorial Hospital for Lung Diseases, 91-520 Lodz, Poland.

ORCID-Profile: Kamil Siekacz, Joanna Miłkowska-Dymanowska, Krystian Bartczak, Sebastian Majewski, Wojciech J Piotrowski, Adam J Białas

Zitieren

APA

Siekacz, K., Kumor-Kisielewska, A., Miłkowska-Dymanowska, J., Pietrusińska, M., Bartczak, K., Majewski, S., Stańczyk, A., Piotrowski, W. J., & Białas, A. J. (2023). Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications. Journal of Clinical Medicine, 12(13), 4253. https://doi.org/10.3390/jcm12134253

Vancouver

Siekacz K, Kumor-Kisielewska A, Miłkowska-Dymanowska J, Pietrusińska M, Bartczak K, Majewski S, et al. Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications. Journal of Clinical Medicine. 2023;12(13):4253. doi:10.3390/jcm12134253

BibTeX
@article{Siekacz2023,
  author = {Siekacz, Kamil and Kumor-Kisielewska, Anna and Miłkowska-Dymanowska, Joanna and Pietrusińska, Małgorzata and Bartczak, Krystian and Majewski, Sebastian and Stańczyk, Adam and Piotrowski, Wojciech J and Białas, Adam J},
  title = {Oxidative Biomarkers Associated with the Pulmonary Manifestation of Post-COVID-19 Complications},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {13},
  pages = {4253},
  doi = {10.3390/jcm12134253}
}
Kostenlos starten →